Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Net Receivables history
Currency unavailable · from the balance sheet
No Net Receivables data reported for this period type.
Net Receivables vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $25.75M USD | +44.0% | +187.9% | 7.8% | |
| Jun 2026 | $13.42M USD | -52.0% | +342.2% | 1.5% | |
| Mar 2026 | $4.81M USD | +1825.6% | +125.7% | 2.4% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | $3.86M USD | -50.9% | +60.9% | 0.7% |
| Mar 2026 | $354K USD | -43.9% | +140.6% | 0.2% | |
| Sep 2026 | $0 USD | — | — | 0.0% | |
ORKAOruka Therapeutics, Inc. | Sep 2026 | $0 USD | — | — | 0.0% |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €0 EUR | — | — | 0.0% |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | -43.9% | +140.6% | 0.4% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.